Vitamin D Receptor Activation By Paricalcitol and Insulin Resistance in CKD

The nature of the link (causal vs non-causal) between low 1,25-OH vitamin D and insulin resistance (IR) in patients with chronic kidney disease (CKD) remains elusive. We have now made a post hoc analysis of the effect of vitamin D receptor activation by paricalcitol on IR in the complete dataset of a double-blind, randomized, placebo controlled trial, the Paracalcitol and ENdothelial fuNction in chronic kidneY disease (PENNY).

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - December 7, 2017 Category: Nutrition Authors: B. Spoto, P. Pizzini, S. Cutrupi, G. Tripepi, G. Curatola, F. Mallamaci, C. Zoccali Source Type: research